Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
7.11
-0.14 (-1.93%)
At close: Mar 6, 2026, 4:00 PM EST
7.00
-0.11 (-1.55%)
After-hours: Mar 6, 2026, 6:57 PM EST
ARCT Employees
As of December 31, 2025, Arcturus Therapeutics Holdings had 111 total employees, including 106 full-time and 5 part-time employees. The number of employees decreased by 65 or -36.93% compared to the previous year.
Employees
111
Change (1Y)
-65
Growth (1Y)
-36.93%
Revenue / Employee
$739,018
Profits / Employee
-$592,640
Market Cap
202.09M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Editas Medicine | 246 |
| Humacyte | 220 |
| Protalix BioTherapeutics | 213 |
| Voyager Therapeutics | 172 |
| Cibus | 159 |
| Tenaya Therapeutics | 97 |
| Compugen | 74 |
| Acumen Pharmaceuticals | 61 |
ARCT News
- 2 days ago - Arcturus Therapeutics to Attend Upcoming Investor Conference - Business Wire
- 3 days ago - Arcturus Therapeutics Holdings Inc. (ARCT) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Pipeline Progress - Business Wire
- 18 days ago - Arcturus Therapeutics to Report Fourth Quarter and Fiscal Year 2025 Financial Results and Provide Corporate Update on March 3, 2026 - Business Wire
- 23 days ago - Arcturus Therapeutics: Two Catalysts, One Runway, And A Stock Priced For Failure - Seeking Alpha
- 2 months ago - Arcturus Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
- 4 months ago - Arcturus Therapeutics Holdings Inc. (ARCT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress - Business Wire